search
Back to results

VR to Evaluate Phantom Limb Pain

Primary Purpose

Phantom Limb Pain, Phantom Pain, Phantom Sensation

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Coapt Phantom Limb Pain Management System
Sponsored by
Shirley Ryan AbilityLab
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Phantom Limb Pain focused on measuring Virtual Reality, Limb Loss, Amputation, Phantom Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adults over the age of 18 years old Amputation of the upper or lower limb, including amputation of multiple limbs English Speaking Chronic phantom limb pain (at least 6-months duration) Average phantom limb pain intensity of 4 or greater on a 0-10 numerical rating scale Average frequency of phantom limb pain episode of at least twice per month. Residual limb pain of less than 5 on the Numerical Pain Rating Scale Pain medication use stable for > 1 month Exclusion Criteria Unable to tolerate use of liner or cuff on their residual limb Skin irritation/wounds on residual limb that would prevent use of the electrode cuff Significant cognitive deficits or visual impairment that would preclude them from giving informed consent or following instructions during the experiments, or the ability to obtain relevant user feedback. Non-English speaking

Sites / Locations

  • Shirley Ryan AbilityLabRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Phantom Limb Pain Management System during at-home use.

Arm Description

Participants attend either in person at Shirley Ryan AbilityLab or virtually via Zoom Educational documents provided on pain and phantom limb pain. Participants are measured for an electrode cuff either in person or virtually Complete several questionnaires. Provided training on the Phantom Limb Pain Program with use of the electrode cuff and muscular contractions of their limb Participate in a 8 week home trial (1.5 hours per week of use, 20-40 minutes, 4-5x each week) Once home trial is complete - participants will be asked to participate in a phone or Zoom call at weeks 16,24 and 32 to repeat questionnaires.

Outcomes

Primary Outcome Measures

Short-form McGill Pain Questionnaire
The primary outcome measure in this study is change in the pain rating index (PRI) between the baseline score and at the post-treatment assessment at the end of the 8-week intervention. The PRI is computed as the sum of the scores for all descriptors of the Short Form of the McGill Pain Questionnaire (SF-MPQ).

Secondary Outcome Measures

Visual Analogue Scale (VAS)
The pain VAS is a unidimensional measure of pain intensity, used to record a persons pain progression, or compare pain severity between paints with similar conditions.
Numerical Pain Rating Scale (NPRS)
The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.
Patient-Reported Outcomes Measurement Information Systems (PROMIS)
ROMIS® (Patient-Reported Outcomes Measurement Information System®) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults. PROMIS measures can be used with the general population and with individuals living with chronic conditions.

Full Information

First Posted
June 13, 2023
Last Updated
June 13, 2023
Sponsor
Shirley Ryan AbilityLab
Collaborators
Coapt, LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT05915065
Brief Title
VR to Evaluate Phantom Limb Pain
Official Title
Intuitively Controlled Virtual Reality to Treat Phantom Limb Pain
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
September 30, 2024 (Anticipated)
Study Completion Date
September 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shirley Ryan AbilityLab
Collaborators
Coapt, LLC

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity amputation. We hypothesize that the system will improve PLP for individuals with upper or lower extremity amputation, as measured through with various outcome measures and questionnaires.
Detailed Description
The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity limb absence. Phase 1: Complete in-lab or virtual iterative usability and functionality testing of hardware and software components of The Coapt Phantom Limb Pain Management System to ensure readiness for at-home use - COMPLETED Phase 2: A clinical trial of The Coapt Phantom Limb Pain Management System during at-home use. We hypothesize that the system will improve PLP for individuals with upper or lower extremity absence, as measured through various questionnaires. VR systems have been proposed as alternative technologies to treat PLP since they are relatively inexpensive and more readily available. Virtual reality environments allow for real-time control practice utilizing different tasks and games, and have been widely accepted as clinically viable options for administering therapy. Effective PLP treatment methods are needed for individuals with limb absence that can be utilized on an as-needed basis in the home. VR therapy could potentially be an effective treatment for individuals with chronic upper or lower limb PLP.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Phantom Limb Pain, Phantom Pain, Phantom Sensation, Phantom Limb Syndrome With Pain, Phantom Pain Following Amputation of Lower Limb, Phantom Pain Following Amputation of Upper Limb, Amputation, Upper Limb Amputation at the Hand, Upper Limb Amputation at the Wrist, Upper Limb Amputation Below Elbow (Injury), Upper Limb Amputation Above Elbow (Injury), Lower Limb Amputation Knee, Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation Below Knee (Injury), Lower Limb Amputation at Ankle (Injury)
Keywords
Virtual Reality, Limb Loss, Amputation, Phantom Pain

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This study will enroll one, non-random group of amputees to participate in 2-4 in person or virtual research visits, participate in a home trial and complete questionnaires pre home trial, at various points during the home trial and upon conclusion of the home trial.
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Phantom Limb Pain Management System during at-home use.
Arm Type
Other
Arm Description
Participants attend either in person at Shirley Ryan AbilityLab or virtually via Zoom Educational documents provided on pain and phantom limb pain. Participants are measured for an electrode cuff either in person or virtually Complete several questionnaires. Provided training on the Phantom Limb Pain Program with use of the electrode cuff and muscular contractions of their limb Participate in a 8 week home trial (1.5 hours per week of use, 20-40 minutes, 4-5x each week) Once home trial is complete - participants will be asked to participate in a phone or Zoom call at weeks 16,24 and 32 to repeat questionnaires.
Intervention Type
Device
Intervention Name(s)
Coapt Phantom Limb Pain Management System
Intervention Description
The PLP-MS consists of (1) an expandable arm/leg cuff with electrode sensors to collect EMG signals from residual limb muscles, (2) an integrated hardware module (the Coapt Complete Control Gen2.5 system) that translates users' EMG signals into game commands, (3) game software for mobile applications, and (4) a secure, HIPAA-compliant cloud-based data storage system for storing and retrieving user data remotely.
Primary Outcome Measure Information:
Title
Short-form McGill Pain Questionnaire
Description
The primary outcome measure in this study is change in the pain rating index (PRI) between the baseline score and at the post-treatment assessment at the end of the 8-week intervention. The PRI is computed as the sum of the scores for all descriptors of the Short Form of the McGill Pain Questionnaire (SF-MPQ).
Time Frame
Baseline score and at the post-treatment assessment at the end of the 8-week intervention
Secondary Outcome Measure Information:
Title
Visual Analogue Scale (VAS)
Description
The pain VAS is a unidimensional measure of pain intensity, used to record a persons pain progression, or compare pain severity between paints with similar conditions.
Time Frame
Baseline score and at the post-treatment assessment at the end of the 8-week intervention
Title
Numerical Pain Rating Scale (NPRS)
Description
The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.
Time Frame
Baseline score and at the post-treatment assessment at the end of the 8-week intervention
Title
Patient-Reported Outcomes Measurement Information Systems (PROMIS)
Description
ROMIS® (Patient-Reported Outcomes Measurement Information System®) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults. PROMIS measures can be used with the general population and with individuals living with chronic conditions.
Time Frame
Baseline score and at the post-treatment assessment at the end of the 8-week intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults over the age of 18 years old Amputation of the upper or lower limb, including amputation of multiple limbs English Speaking Chronic phantom limb pain (at least 6-months duration) Average phantom limb pain intensity of 4 or greater on a 0-10 numerical rating scale Average frequency of phantom limb pain episode of at least twice per month. Residual limb pain of less than 5 on the Numerical Pain Rating Scale Pain medication use stable for > 1 month Exclusion Criteria Unable to tolerate use of liner or cuff on their residual limb Skin irritation/wounds on residual limb that would prevent use of the electrode cuff Significant cognitive deficits or visual impairment that would preclude them from giving informed consent or following instructions during the experiments, or the ability to obtain relevant user feedback. Non-English speaking
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Suzanne Finucane
Phone
312-238-0937
Email
sfinucane@sralab.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Levi Hargrove, PhD
Organizational Affiliation
Shirley Ryan AbilityLab
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shirley Ryan AbilityLab
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Suzanne Finucane
Phone
312-238-0937
Email
sfinucane@sralab.org
First Name & Middle Initial & Last Name & Degree
Levi Hargrove, PhD

12. IPD Sharing Statement

Learn more about this trial

VR to Evaluate Phantom Limb Pain

We'll reach out to this number within 24 hrs